Atypical Antipsychotic Treatment of Children and Adolescents and Treatment-Emergent Diabetes

ISSN： 1085-0295

Source： Child and Adolescent Psychopharmacology News, Vol.8, Iss.3, 2003-05, pp. : 4-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment-emergent adverse events associated with atypical antipsychotics

By Cha Danielle S McIntyre Roger S

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 11, 2012-08 ,pp. : 1587-1598

Informa Healthcare

Access to resources Recommend Favorite

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

By Müüller Daniel J Kennedy James L

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 863-887

Future Medicine

Access to resources Recommend Favorite

Management of Atypical Antipsychotic Induced Prolactin Elevation in Children and Adolescents

Child and Adolescent Psychopharmacology News, Vol. 18, Iss. 1, 2013-02 ,pp. : 1-6

Guilford Publications Inc

Access to resources Recommend Favorite

Increasing Incidence of Type 2 Diabetes in Children and Adolescents: Treatment Considerations

By Rosenbloom A.L.

Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. : 209-221

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Atypical Antipsychotics in the Treatment of Schizophrenia and Comorbid Disorders in Children and Adolescents

By Paz Toren Sharon Ratner Nathaniel Laor Abraham Weizman

Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. : 1135-1156

Adis International

Access to resources Recommend Favorite